Medications like semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) help people lose significant amounts of weight often 1520% of their body weight over about a year
Sometimes, the most important pharmacovigilance insights emerge not from clinical trials, but from real-world adverse event reporting
Individual results may vary, but many patients experience significant weight loss of 5-10% of their body weight or more within a few months of starting treatment
Most studies evaluating BPC-157, thymosin beta-4 derivatives, and related peptide agents are preclinical, employ heterogeneous dosing regimens, and report surrogate endpoints that do not translate directly to operative recovery or implant-based outcomes
Contrave was FDA approved in 2014 as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adults in the presence of at least one weight-related comorbid medical condition
B12 shots are commonly prescribed to individuals with B12 deficiencies, which can occur due to factors such as dietary restrictions, malabsorption issues, or certain medical conditions